Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy

Michael L. Cher, Fernando J. Bianco, John S. Lam, Lawrence P. Davis, David Grignon, Wael A. Sakr, Mousumi Banerjee, J. Edson Pontes, David P. Wood

Research output: Contribution to journalArticle

222 Citations (Scopus)

Abstract

Purpose: Bone scintigrams of patients with increasing serum prostate specific antigen (PSA) after radical prostatectomy are only rarely positive. We identify clinical parameters that would improve our ability to select patients for this imaging study. Materials and Methods: We reviewed all bone scintigrams done at our institution between 1991 and 1996 in patients with persistently increasing serum PSA after radical prostatectomy. What prompted the clinician to obtain the bone scintigram was trigger PSA (tPSA). The rate of increase in PSA to tPSA was measured by tPSA/time from radical prostatectomy (slope 1) and tPSA/time from last undetectable PSA (slope 2). These parameters were evaluated together with standard clinicopathological data in univariate and multivariate analyses to determine the ability to predict the bone scintigram result. Results: In univariate analysis tPSA (p = 0.003), slope 1 (p = 0.005) and slope 2 (p = 0.004) were useful in predicting the bone scintigram result but pathological stage, Gleason score, preoperative PSA and time to recurrence were not. In multivariate analysis the single most useful parameter in predicting the bone scintigram result was tPSA (p = 0.01). Based on a logistic regression model the probability of a positive bone scintigram was less than 5% until tPSA increased to 40 to 45 ng./ml. Conclusions: In patients with increasing serum PSA after radical prostatectomy current serum PSA is the best predictor of the bone scintigram result. Furthermore, there is limited usefulness of bone scintigraphy until PSA increases above 30 to 40 ng./ml.

Original languageEnglish
Pages (from-to)1387-1391
Number of pages5
JournalJournal of Urology
Volume160
Issue number4
DOIs
StatePublished - Oct 1998
Externally publishedYes

Fingerprint

Prostate-Specific Antigen
Prostatectomy
Radioisotopes
Radionuclide Imaging
Bone and Bones
Serum
Multivariate Analysis
Logistic Models
Neoplasm Grading
Recurrence

Keywords

  • Bone and bones
  • Prostate-specific antigen
  • Prostatectomy
  • Radionuclide imaging

ASJC Scopus subject areas

  • Urology

Cite this

Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. / Cher, Michael L.; Bianco, Fernando J.; Lam, John S.; Davis, Lawrence P.; Grignon, David; Sakr, Wael A.; Banerjee, Mousumi; Pontes, J. Edson; Wood, David P.

In: Journal of Urology, Vol. 160, No. 4, 10.1998, p. 1387-1391.

Research output: Contribution to journalArticle

Cher, Michael L. ; Bianco, Fernando J. ; Lam, John S. ; Davis, Lawrence P. ; Grignon, David ; Sakr, Wael A. ; Banerjee, Mousumi ; Pontes, J. Edson ; Wood, David P. / Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. In: Journal of Urology. 1998 ; Vol. 160, No. 4. pp. 1387-1391.
@article{2c2f869669514f3fb724615d778c5897,
title = "Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy",
abstract = "Purpose: Bone scintigrams of patients with increasing serum prostate specific antigen (PSA) after radical prostatectomy are only rarely positive. We identify clinical parameters that would improve our ability to select patients for this imaging study. Materials and Methods: We reviewed all bone scintigrams done at our institution between 1991 and 1996 in patients with persistently increasing serum PSA after radical prostatectomy. What prompted the clinician to obtain the bone scintigram was trigger PSA (tPSA). The rate of increase in PSA to tPSA was measured by tPSA/time from radical prostatectomy (slope 1) and tPSA/time from last undetectable PSA (slope 2). These parameters were evaluated together with standard clinicopathological data in univariate and multivariate analyses to determine the ability to predict the bone scintigram result. Results: In univariate analysis tPSA (p = 0.003), slope 1 (p = 0.005) and slope 2 (p = 0.004) were useful in predicting the bone scintigram result but pathological stage, Gleason score, preoperative PSA and time to recurrence were not. In multivariate analysis the single most useful parameter in predicting the bone scintigram result was tPSA (p = 0.01). Based on a logistic regression model the probability of a positive bone scintigram was less than 5{\%} until tPSA increased to 40 to 45 ng./ml. Conclusions: In patients with increasing serum PSA after radical prostatectomy current serum PSA is the best predictor of the bone scintigram result. Furthermore, there is limited usefulness of bone scintigraphy until PSA increases above 30 to 40 ng./ml.",
keywords = "Bone and bones, Prostate-specific antigen, Prostatectomy, Radionuclide imaging",
author = "Cher, {Michael L.} and Bianco, {Fernando J.} and Lam, {John S.} and Davis, {Lawrence P.} and David Grignon and Sakr, {Wael A.} and Mousumi Banerjee and Pontes, {J. Edson} and Wood, {David P.}",
year = "1998",
month = "10",
doi = "10.1016/S0022-5347(01)62545-X",
language = "English",
volume = "160",
pages = "1387--1391",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy

AU - Cher, Michael L.

AU - Bianco, Fernando J.

AU - Lam, John S.

AU - Davis, Lawrence P.

AU - Grignon, David

AU - Sakr, Wael A.

AU - Banerjee, Mousumi

AU - Pontes, J. Edson

AU - Wood, David P.

PY - 1998/10

Y1 - 1998/10

N2 - Purpose: Bone scintigrams of patients with increasing serum prostate specific antigen (PSA) after radical prostatectomy are only rarely positive. We identify clinical parameters that would improve our ability to select patients for this imaging study. Materials and Methods: We reviewed all bone scintigrams done at our institution between 1991 and 1996 in patients with persistently increasing serum PSA after radical prostatectomy. What prompted the clinician to obtain the bone scintigram was trigger PSA (tPSA). The rate of increase in PSA to tPSA was measured by tPSA/time from radical prostatectomy (slope 1) and tPSA/time from last undetectable PSA (slope 2). These parameters were evaluated together with standard clinicopathological data in univariate and multivariate analyses to determine the ability to predict the bone scintigram result. Results: In univariate analysis tPSA (p = 0.003), slope 1 (p = 0.005) and slope 2 (p = 0.004) were useful in predicting the bone scintigram result but pathological stage, Gleason score, preoperative PSA and time to recurrence were not. In multivariate analysis the single most useful parameter in predicting the bone scintigram result was tPSA (p = 0.01). Based on a logistic regression model the probability of a positive bone scintigram was less than 5% until tPSA increased to 40 to 45 ng./ml. Conclusions: In patients with increasing serum PSA after radical prostatectomy current serum PSA is the best predictor of the bone scintigram result. Furthermore, there is limited usefulness of bone scintigraphy until PSA increases above 30 to 40 ng./ml.

AB - Purpose: Bone scintigrams of patients with increasing serum prostate specific antigen (PSA) after radical prostatectomy are only rarely positive. We identify clinical parameters that would improve our ability to select patients for this imaging study. Materials and Methods: We reviewed all bone scintigrams done at our institution between 1991 and 1996 in patients with persistently increasing serum PSA after radical prostatectomy. What prompted the clinician to obtain the bone scintigram was trigger PSA (tPSA). The rate of increase in PSA to tPSA was measured by tPSA/time from radical prostatectomy (slope 1) and tPSA/time from last undetectable PSA (slope 2). These parameters were evaluated together with standard clinicopathological data in univariate and multivariate analyses to determine the ability to predict the bone scintigram result. Results: In univariate analysis tPSA (p = 0.003), slope 1 (p = 0.005) and slope 2 (p = 0.004) were useful in predicting the bone scintigram result but pathological stage, Gleason score, preoperative PSA and time to recurrence were not. In multivariate analysis the single most useful parameter in predicting the bone scintigram result was tPSA (p = 0.01). Based on a logistic regression model the probability of a positive bone scintigram was less than 5% until tPSA increased to 40 to 45 ng./ml. Conclusions: In patients with increasing serum PSA after radical prostatectomy current serum PSA is the best predictor of the bone scintigram result. Furthermore, there is limited usefulness of bone scintigraphy until PSA increases above 30 to 40 ng./ml.

KW - Bone and bones

KW - Prostate-specific antigen

KW - Prostatectomy

KW - Radionuclide imaging

UR - http://www.scopus.com/inward/record.url?scp=0032323478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032323478&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)62545-X

DO - 10.1016/S0022-5347(01)62545-X

M3 - Article

VL - 160

SP - 1387

EP - 1391

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -